Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer

Human Reproduction

Volumn 22, Issue 6, 2007, Pages 1573-1577

  Menon, U ^a   Harper, J ^a   Sharma, A ^a   Fraser, L ^a   Burnell, M ^a   El Masry, K ^a   Rodeck, C ^a   Jacobs, I ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

BRCA; Preimplantation diagnosis; Reproductive options

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; NUCLEAR PROTEIN; PROTEIN BRCA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEALTH SURVEY; HETEROZYGOTE; HUMAN; LICENSING; OVARY CANCER; PREIMPLANTATION GENETIC DIAGNOSIS; PRENATAL DIAGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 34447330141     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem055     Document Type: Article

References (14)

1. Antoniou A, Pharoah PD, Narod S et al. Average risks of breast and ovarian 1cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
2. Ao A, Wells D, Handyside AH, Winston RM, Delhanty JD. Preimplantation genetic diagnosis of inherited cancer: Familial adenomatous polyposis coli. J Assist Reprod Genet 1998;15(3):140-144.
3. Harper JC, Boelaert K, Geraedts J et al. ESHRE PGD Consortium data collection V: Cycles from January to December 2002 with pregnancy follow-up to October 2003. Hum Reprod 2006;21:3-21.
4. Henneman L, Bramsen I, Van Os TA et al. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF). Prenat Diagn 2001;21 1-9.
5. HFEA. Authority decision on PGD policy (http://www.hfea.gov.uk/cps/rde/ xchg/SID-3F57D79B-D0A79FB/hfea/hs.xsl/1124.html), 2006.
6. HFEA. Choices and Boundaries Report (http://www.hfea.gov.uk/cps/rde/xbcr/ SID-3F57D79B-377BEC8F/hfea/Choices_and_boundaries_Report_2006.pdf), 2006.
7. Lavery SA, Aurell R, Turner C et al. Preimplantation genetic diagnosis: Patients' experiences and attitudes. Hum Reprod 2002; 17:2464-2467.
8. Mays N, Pope C. Rigour and qualitative research. BMJ 1995;311 109-112.
9. Meister U, Finck C, Stobel-Richter Y et al. Knowledge and attitudes towards preimplantation genetic diagnosis in Germany. Hum Reprod 2005;20: 231-238.
10. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ 2000;320:114-116.
11. Robertson JA. Extending preimplantation genetic diagnosis: The ethical debate. Ethical issues in new uses of preimplantation genetic diagnosis. Hum Reprod 2003;18:465-471.
12. Sermon K, Moutou C, Harper J et al. ESHRE PGD Consortium data collection IV: May-December 2001. Hum Reprod 2005;20:19-34.
13. Snowdon C, Green JM. Preimplantation diagnosis and other reproductive options: Attitudes of male and female carriers of recessive disorders. Hum Reprod 1997;12:341-350.
14. Sogaard M, Kjaer SK, Gayther S. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 2006;85:93-105.